CB 003Alternative Names: CB-003; GC enriched liposomal vinorelbine - Ceronco Biosciences; Glucosylceramide enriched liposomal vinorelbine - Ceronco Biosciences; Vinorelbine liposomal - Ceronco Biosciences
Latest Information Update: 27 Oct 2016
At a glance
- Originator Ceronco Biosciences
- Class Antineoplastics; Small molecules; Vinca alkaloids
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 26 Oct 2016 Preclinical trials in Cancer in Netherlands (unspecified route)